Exploratory screening of EPO, BMP-2 and reamer-irrigator-aspirator liquid phase in serum-free 3D fibrin cultures of freshly isolated human bone marrow mononuclear cells
Introduction Bone healing is a complex process involving coordinated spatio-temporal cellular and molecular events. Despite advances in orthopedic research the mechanisms underlying impaired fracture healing remain poorly understood and effective therapies are limited. Although cytokines and growth factors have shown regenerative potential, conventional 2D cell culture models fail to recapitulate the cellular composition and physiological microenvironment required for translational research. Methods We established 3D bone marrow mononuclear cell (BMMC) hydrogel models to better mimic the native bone healing niche and investigate the effects of Reamer-Irrigator-Aspirator liquid phase (RIA-liquid), recombinant erythropoietin (EPO), and recombinant bone morphogenetic protein-2 (BMP-2) on bone healing-related cellular responses. Rat collagen and human plasma fibrin hydrogels supplemented with human plasma fibronectin were compared for their ability to preserve freshly isolated femoral BMMCs. Results Both collagen- and fibrin based hydrogels were generated, but only fibrin supported sufficient viable BMMC retrieval in this setting. Cells were characterized by flow cytometry and cultured for 3 days with respective stimuli. Hydrogel lysates were analyzed for changes in surface marker composition. In this simplified 3D model, a higher frequency of CD31+ cells and lower frequency of CD3 + CD8 + T cells as response upon RIA-liquid treatment could be observed, whereas under these experimental conditions, no statistically significant changes were observed for EPO and BMP-2. Allogeneic RIA-liquid was associated with exploratory changes in T cell subsets ( n = 3), whereas under these experimental conditions no statistically significant changes were observed for EPO and BMP-2 ( n = 7). Conclusion This 3D fibrin culture system retains a heterogeneous cell mixture from freshly isolated BMMCs after three days. It is suitable for follow-up studies with larger cohorts and higher event counts.
Authors
- Torsten Blunk (ORCID: https://orcid.org/0000-0003-1050-6753)
- M. Herrmann
- S. Haeusner
- A. Kolb
Institutions
- University of Würzburg (DE)
- Universitätsklinikum Würzburg (DE)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2026-11-12
- DOI
- https://doi.org/10.3389/fmed.2026.1943539
- Primary Topic
- Bone fractures and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Bundesministerium für Bildung und Forschung
- Julius-Maximilians-Universität Würzburg
- Graduate School of Life Sciences, Julius-Maximilians-Universität Würzburg